Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Single Nucleotide Polymorphisms-SNPs

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...

Cystic Fibrosis: Pathogenesis

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Refining Human Phenotype Ontology (HPO) to enable better phenotype-genotype integration in systemic autoimmune rheumatic diseases.

Orphanet journal of rare diseases·2026

Same author

Identifying candidate core domains for clinical trials in systemic sclerosis-associated Raynaud's phenomenon and digital ulcers.

Seminars in arthritis and rheumatism·2026

Same author

Influence of comorbidities and patient demographics on Raynaud's symptom characteristics: implications for diagnosis and management.

Journal of scleroderma and related disorders·2026

Same author

Novel HLA class I and II insights into the pathogenesis of systemic sclerosis-associated interstitial lung disease.

Annals of the rheumatic diseases·2026

Same author

The clinical utility of telangiectasia quantification as markers of vascular disease progression in systemic sclerosis.

Rheumatology (Oxford, England)·2026

Same author

Assessing post-cold challenge recovery of thermography as a potential outcome measure in trials of SSc-related Raynaud's phenomenon.

Scientific reports·2026

Search research articles

Related Experiment Video

Updated: Jul 8, 2026

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

Polymorphisms in COL15 gene are not associated with systemic sclerosis.

Sudeep P Pushpakom¹, Ariane L Herrick, Shant Kumar

¹National Genetics Reference Laboratory, Department of Medical Genetics, St. Mary's Hospital, Hathersage Road, Manchester M13 0JH, UK. sudeep.parameshwar@cmmc.nhs.uk

The Journal of Rheumatology

|January 19, 2008

Summary

This study investigated the association between COL15 single-nucleotide polymorphisms (SNPs) and systemic sclerosis (SSc) development. No significant association was found, suggesting COL15 may not play a direct role in SSc pathogenesis.

More Related Videos

SorLA and CLC:CLF-1-dependent Downregulation of CNTFRα as Demonstrated by Western Blotting, Inhibition of Lysosomal Enzymes, and Immunocytochemistry

SorLA and CLC:CLF-1-dependent Downregulation of CNTFRα as Demonstrated by Western Blotting, Inhibition of Lysosomal Enzymes, and Immunocytochemistry

Published on: January 6, 2017

Related Experiment Videos

Last Updated: Jul 8, 2026

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

SorLA and CLC:CLF-1-dependent Downregulation of CNTFRα as Demonstrated by Western Blotting, Inhibition of Lysosomal Enzymes, and Immunocytochemistry

SorLA and CLC:CLF-1-dependent Downregulation of CNTFRα as Demonstrated by Western Blotting, Inhibition of Lysosomal Enzymes, and Immunocytochemistry

Published on: January 6, 2017

Area of Science:

Genetics
Rheumatology
Vascular Biology

Background:

Systemic sclerosis (SSc) involves microvascular abnormalities and deregulated angiogenesis.
The vascular basement membrane, including collagen type XV (COL15), is crucial for angiogenesis.
COL15 gene expression is altered in SSc patients, prompting investigation into its genetic role.

Purpose of the Study:

To explore the association between COL15 single-nucleotide polymorphisms (SNPs) and the development of SSc.
To determine if genetic variations in COL15 contribute to SSc susceptibility.

Main Methods:

Genotyping of eleven SNPs across the COL15 gene in 175 UK Caucasian SSc patients and 190 healthy controls.
Utilized TaqMan and SNaPshot methods for genotyping.
Statistical analysis included Pearson's chi-square test and haplotype analysis with HelixTree software.

Main Results:

No significant differences in genotype or allele frequencies of COL15 SNPs were observed between SSc patients and controls.
Haplotype frequency analysis also revealed no significant differences between the groups.

Conclusions:

The study did not find a significant association between the investigated COL15 SNPs and SSc.
The lack of association may indicate a true absence of linkage or a false-negative result due to limited statistical power.
Larger cohorts may be required to definitively exclude COL15's role in SSc development.